All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 24304454)

Published in J Viral Hepat on June 10, 2013

Authors

L M Hagan1, Z Yang, M Ehteshami, R F Schinazi

Author Affiliations

1: Department of Pediatrics, Laboratory of Biochemical Pharmacology, Center for AIDS Research, Emory University School of Medicine, Atlanta, GA, USA; Emory University Rollins School of Public Health, Atlanta, GA, USA; Veterans Affairs Medical Center, Decatur, GA, USA.

Articles citing this

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals. Hepatology (2014) 2.17

Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med (2015) 2.07

Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med (2016) 1.77

Clinical impact of treatment timing for chronic hepatitis C infection: a decision model. J Viral Hepat (2015) 1.40

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05

Impact of all oral anti-hepatitis C virus therapy: A meta-analysis. World J Hepatol (2015) 0.88

The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS (2014) 0.87

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget (2015) 0.84

Hepatitis C screening. Ochsner J (2014) 0.83

Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol (2015) 0.79

Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C. Hepatology (2015) 0.79

Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence. Infect Dis Ther (2016) 0.79

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care. Medicine (Baltimore) (2016) 0.77

Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther (2016) 0.76

New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison. Cost Eff Resour Alloc (2015) 0.75

Cost-effectiveness and access to care in the treatment of hepatitis C virus infection. Gastroenterol Hepatol (N Y) (2014) 0.75

US-Based Drug Cost Parameter Estimation for Economic Evaluations. Med Decis Making (2014) 0.75

Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway. BMC Infect Dis (2017) 0.75

Articles by these authors

A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol (1994) 19.91

Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics (1998) 11.25

Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet (1998) 6.09

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol (2000) 5.76

Estimation of primate speciation dates using local molecular clocks. Mol Biol Evol (2000) 5.06

Probability distribution of molecular evolutionary trees: a new method of phylogenetic inference. J Mol Evol (1996) 4.95

Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol (2001) 4.03

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. Proc Natl Acad Sci U S A (1991) 3.82

Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81

The CLAVATA1 receptor-like kinase requires CLAVATA3 for its assembly into a signaling complex that includes KAPP and a Rho-related protein. Plant Cell (1999) 3.62

A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet (2001) 3.52

Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci (2000) 3.48

Control of pollen tube tip growth by a Rop GTPase-dependent pathway that leads to tip-localized calcium influx. Plant Cell (1999) 3.32

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27

Immunization for Ebola virus infection. Nat Med (1998) 3.27

Total synthesis of taxol. Nature (1994) 3.22

Patterns of tuberculosis transmission in Central Los Angeles. JAMA (1997) 3.21

Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis (1997) 3.18

Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol (1998) 3.11

Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron (2000) 2.94

Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol (1996) 2.91

Positive Darwinian selection drives the evolution of several female reproductive proteins in mammals. Proc Natl Acad Sci U S A (2001) 2.80

Rop GTPase-dependent dynamics of tip-localized F-actin controls tip growth in pollen tubes. J Cell Biol (2001) 2.80

PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother (1997) 2.64

Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation (2001) 2.41

Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40

The geography of availability and driving after drinking. Addiction (1996) 2.39

Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37

Synthesis of epothilones A and B in solid and solution phase. Nature (1997) 2.35

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology (2001) 2.30

Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29

Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol (1998) 2.19

Arabidopsis Rho-related GTPases: differential gene expression in pollen and polar localization in fission yeast. Plant Physiol (1998) 2.18

Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord (2004) 2.15

Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15

DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 2.11

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis (1999) 2.07

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J Clin Invest (2001) 2.05

Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A (2005) 1.95

The Rop GTPase switch controls multiple developmental processes in Arabidopsis. Plant Physiol (2001) 1.93

Substitution rate variation among sites in mitochondrial hypervariable region I of humans and chimpanzees. Mol Biol Evol (1999) 1.90

Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.90

Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus. Biochem Pharmacol (1987) 1.89

Present-day crustal deformation in China constrained by global positioning system measurements. Science (2001) 1.87

A genome-wide analysis of Arabidopsis Rop-interactive CRIB motif-containing proteins that act as Rop GTPase targets. Plant Cell (2001) 1.80

Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med (1997) 1.76

Preponderance of slightly deleterious polymorphism in mitochondrial DNA: nonsynonymous/synonymous rate ratio is much higher within species than between species. Mol Biol Evol (1998) 1.76

Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J (1996) 1.75

Taxon sampling and the accuracy of large phylogenies. Syst Biol (1998) 1.75

Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob Agents Chemother (2001) 1.72

Transmission of Mycobacterium tuberculosis from medical waste. JAMA (2000) 1.67

Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. Proc Natl Acad Sci U S A (1994) 1.67

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (2000) 1.60

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med (1991) 1.59

Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther (2010) 1.58

Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens (2008) 1.57

Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects. Cancer Gene Ther (2006) 1.56

Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase. Biochem Pharmacol (1993) 1.56

Structural features of the cytoplasmic region of CD4 required for internalization. EMBO J (1990) 1.56

Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54

Shear stress increases Cu/Zn SOD activity and mRNA expression in human endothelial progenitor cells. J Hum Hypertens (2007) 1.54

Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem (1994) 1.53

A new complex of palladium-thiourea and carbon tetrabromide catalyzed carbonylative annulation of o-hydroxylarylacetylenes: efficient new synthetic technology for the synthesis of 2,3-disubstituted benzo[b]furans. Org Lett (2000) 1.53

The Rop GTPase: an emerging signaling switch in plants. Plant Mol Biol (2000) 1.53

How often do wrong models produce better phylogenies? Mol Biol Evol (1997) 1.52

The Rrop GTPase switch turns on polar growth in pollen. Trends Plant Sci (2000) 1.52

Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens (2006) 1.51

Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol (2000) 1.51

Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus (2012) 1.50

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50

Arabidopsis RopGAPs are a novel family of rho GTPase-activating proteins that require the Cdc42/Rac-interactive binding motif for rop-specific GTPase stimulation. Plant Physiol (2000) 1.49

Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates. Antimicrob Agents Chemother (2000) 1.49

Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob Agents Chemother (1982) 1.48

The incidence of false-positive cultures for Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 1.48

Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med (1996) 1.48

Effect of cellular filamentation on adventurous and social gliding motility of Myxococcus xanthus. Proc Natl Acad Sci U S A (1999) 1.47

Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol (2001) 1.45

Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob Agents Chemother (1994) 1.43

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest (1995) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Modulation of kir4.1 and kir5.1 by hypercapnia and intracellular acidosis. J Physiol (2000) 1.41

Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (1981) 1.41

A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res (2001) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

A cocoon of freshly accelerated cosmic rays detected by Fermi in the Cygnus superbubble. Science (2011) 1.39

[The effects of massive escharectomy on the resuscitation of burn shock in the early stage after burn]. Zhonghua Shao Shang Za Zhi (2000) 1.39

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. Antimicrob Agents Chemother (1995) 1.39

Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res (1995) 1.39

Characterization of KIFC2, a neuronal kinesin superfamily member in mouse. Neuron (1997) 1.39

Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis (2001) 1.38

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med (1995) 1.38

Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem (1998) 1.38

Rapid test for identification of heat-labile enterotoxin-producing Escherichia coli colonies. J Clin Microbiol (1983) 1.37

Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37